Erratum to Regulatory acceptance and use of serology for inactivated veterinary rabies vaccines

Most read articles by the same author(s)

• Katya Tsaioun, Bas J. Blaauboer, Thomas Hartung, Evidence-based absorption, distribution, metabolism, excretion (ADME) and its interplay with alternative toxicity methods , ALTEX - Alternatives to animal experimentation: Vol. 33 No. 4 (2016)
• Marie-Jeanne W. A. Schiffelers, Bas J. Blaauboer, Wieger E. Bakker, Coenraad F. M. Hendriksen, Regulatory acceptance and use of serology for inactivated veterinary rabies vaccines , ALTEX - Alternatives to animal experimentation: Vol. 32 No. 3 (2015)
• Bas J. Blaauboer, Kim Boekelheide, Harvey J. Clewell, Mardas Daneshian, Milou M. L. Dingemans, Alan M. Goldberg, Marjoke Heneweer, Joanna Jaworska, Nynke I. Kramer, Marcel Leist, Hasso Seibert, Emanuela Testai, Rob J. Vandebriel, James D. Yager, Joanne Zurlo, The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans , ALTEX - Alternatives to animal experimentation: Vol. 29 No. 4 (2012)
• Marie-Jeanne W. A. Schiffelers, Bas J. Blaauboer, Coenraad F. M. Hendriksen, Wieger E. Bakker, Regulatory acceptance and use of 3R models: a multilevel perspective , ALTEX - Alternatives to animal experimentation: Vol. 29 No. 3 (2012)
• Thomas Hartung, Bas J. Blaauboer, Sieto Bosgra, Edward Carney, Joachim Coenen, Rory B. Conolly, Emanuela Corsini, Sidney Green, Elaine M. Faustman, Anthony Gaspari, Makoto Hayashi, A. Wallace Hayes, Jan G. Hengstler, Lisbeth E. Knudsen, Thomas B. Knudsen, James M. McKim, Walter Pfaller, Erwin L. Roggen, An expert consortium review of the EC-commissioned report “Alternative (Non-Animal) Methods for Cosmetics Testing: Current Status and Future Prospects – 2010” , ALTEX - Alternatives to animal experimentation: Vol. 28 No. 3 (2011)
• Marie-Jeanne Schiffelers, Bas Blaauboer, J. Martje Fentener van Vlissingen, Janne Kuil, René Remie, Joop W. G. M. Thuring, Manon A. Vaal, Coenraad F. M. Hendriksen, Factors stimulating or obstructing the implementation of the 3Rs in the regulatory process , ALTEX - Alternatives to animal experimentation: Vol. 24 No. 4 (2007)
• Sigrid Johannes, Joachim Hartinger, Coenraad F. M. Hendriksen, David B. Morton, Klaus Cussler, Humane endpoints in the efficacy testing of swine erysipelas vaccines , ALTEX - Alternatives to animal experimentation: Vol. 20 No. 1 (2003)
• Ans Punt, Hans Bouwmeester, Bas J. Blaauboer, Sandra Coecke, Betty Hakkert, Delilah F. G. Hendriks, Paul Jennings, Nynke I. Kramer, Sibylle Neuhoff, Rosalinde Masereeuw, Alicia Paini, Ad A. C. M. Peijnenburg, Martijn Rooseboom, Michael L. Shuler, Ian Sorrell, Bart Spee, Marije Strikwold, Andries D. van der Meer, Meike van der Zande, Mathieu Vinken, Huan Yang, Peter M. J. Bos, Minne B. Heringa, New approach methodologies (NAMs) for human-relevant biokinetics predictions , ALTEX - Alternatives to animal experimentation: Vol. 37 No. 4 (2020)
• Coenraad F. M. Hendriksen, Recommendations of the ECVAM-Workshop on "Alternatives to Animal Testing in the Quality Control of Immunobiologicals; State of the Art and Future Prospects" , ALTEX - Alternatives to animal experimentation: Vol. 11 No. Supp. 1 (1994): Paul-Ehrlich-Seminar über Tierschutzaspekte bei der Zulassung und Prüfung von immunologischen Arzneimitteln
• Coenraad F. M. Hendriksen, Replacement of the Toxin Neutralisation Test in Mice by in vitro Serological Assay Systems for Potency Testing of Tetanus Toxoid Vaccines for Veterinary Use: Results of a European Collaborative Study , ALTEX - Alternatives to animal experimentation: Vol. 11 No. Supp. 1 (1994): Paul-Ehrlich-Seminar über Tierschutzaspekte bei der Zulassung und Prüfung von immunologischen Arzneimitteln